Of the 18 NF2 alterations, 89% were inactivating frame-shift, splice site, or nonsense alterations, consistent with the known tumor suppressor role of NF2, compared with only 16% of non-NF2 mutations (p = 6 × 10−10). This evidence concerns the gene NF2 and neoplasm.